Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
We describe how low index readings can signal weakening momentum, possible capitulation, or upcoming reversals, with practical interpretation tips.
21,854 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Southwest Airlines is rolling out a new boarding system that is drawing complaints about overhead-bin squeezes and lo...
New Mexico moves to examine decades of coerced sterilizations in Native communities, with findings due by 2027. The i...
A leading Substack economist warns that ghost gdp could erase friction in the economy, accelerating a white-collar re...
The Real Brokerage signs Haley Garcia and her Garcia Real Estate Group to Real Luxury, boosting its luxury footprint ...
Markets shift as political headlines evolve in the days after biggest defeat. This analysis explains how households m...
As mortgage workflows accelerate, industry insiders argue the real hurdle is trust, not velocity. This report examine...
CoreWeave is set to report Q4 2025 results after the close, with investors weighing 2026 guidance amid a legal backdr...
AI investing can feel crowded, but a pair of no-brainer artificial intelligence (ai) stocks stand out for durable gro...
A rare bipartisan effort in the U.S. House seeks to shrink the deficit-to-GDP gap to 3% by 2030, with high-profile ba...
Bitcoin vaulted toward $69,000 in a tight hour, as investors priced in geopolitical headlines and an impending Iran-r...
A seasoned political strategist warns that without a concrete, consumer-focused economic message, Democrats could str...